glp 1 7.5 mg Experts Encourage Use of GLP-1s in Cardiovascular Care Medical Weight Loss GLP-1/GIP |

One study reported that 43.8% of participants who discontinued treatment did so due to nausea and vomiting, while 36.8% stopped because of gastrointestinal discomfort [14]

While many people focus solely on cardio for weight loss, combining it with strength training offers a more well-rounded approach to improving your body composition and breaking through plateaus

[2] [14] This dual-receptor activation distinguishes it from single GLP-1 receptor agonists like semaglutide

Wegovy injection (semaglutide): This is the benchmark weekly GLP-1 injection

The participant must be at least 18 years old and: Have a BMI of 35 or greater, or Have a BMI of 30 or greater with a diagnosis of diastolic heart failure, uncontrolled hypertension or chronic kidney disease Stage 3a or higher, or Have a BMI of 27 or greater with pre-diabetes, previous myocardial infarction or stroke, or symptomatic peripheral artery disease